Expertise
​
We specialise in three core areas that help pharma and healthcare companies move with greater confidence and speed. From launch planning to market access to portfolio strategy, we provide focused, senior-level support that delivers results.
Go-to-market strategy
Clear, confident launch strategy, before the data lands
We help you sharpen your positioning, align internal teams, and build a credible commercial roadmap that reflects market realities.
What we help with:
-
Segmentation and targeting
-
Positioning and value proposition development
-
Launch planning and readiness
-
Cross-functional alignment across medical, market access, and commercial
Market Access Strategy
Build value stories that resonate, with evidence that stands up
We bring deep experience in US and European pricing and reimbursement to help you shape early access strategy, inform evidence plans, and engage confidently with payers.
What we help with:
-
Payer research and insight gathering
-
Value story and core narrative development
-
Early pricing and reimbursement strategy
-
Evidence planning and access gap analysis
Portfolio Optimisation
Prioritise what matters and back it with evidence
We help leadership teams make sharper asset decisions using strategic frameworks grounded in science, market insight, and value potential.
What we help with:
-
Indication prioritisation
-
Portfolio and scenario modelling
-
Commercial and payer input into R&D allocation
-
Investment case support
How it works
Discovery
​
We align on your goals, stakeholders and timelines, and agree the key business questions that need to be answered
Define and test hypotheses
​
We agree working hypotheses then gather the inputs to pressure test them: market data, internal views, HCP and payer perspective etc.
Work up the strategy
​
We draw conclusions from the findings and articulate these in terms of recommended strategies
Agree actions
​
Finally, we recommend ways forward to bring the strategy into effect